Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets. It has three business segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. Its Life Sciences and Applied Markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. The Company's Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.
Industry sector: Computer and Technology
Sector classification: Analytical instruments
Deep Learning based analysis and prediction model for Agilent Technologies, Inc. (A) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.
Model is in the production pipeline since Oct. 2, 2015.
Market data for A model training are being downloaded from the Quandl premium datasets on a daily basis.
Model is being retrained on a daily basis.
|% Held by Insiders||NaN%|
|% Held by Institutions||NaN%|
|EPS (last reported FY)||$1.98|
|EPS (last reported Q)||$0.59|
|EPS, estimated (last reported Q)||$0.52|
|Total revenues||$4 B|
|Net income||$0 B|